Episode #13 Drugs & Politics: Is advocating for drug policy reform a political winner?

Episode #13 Drugs & Politics: Is advocating for drug policy reform a political winner?

In this episode, Rob is joined by Ant Lehane, Policy Lead at Cranstoun. Ant has an extensive amount of experience working within the drug policy arena and discussing such topics with politicians from across the UK.

Is advocating for drug policy reform is a vote winner or loser? Which political party boasts the most progressive drug policies within their manifestos? Will we see significant changes to UK drug policy if Labour wins the next general election? Are politicians, behind closed doors, supportive of changing drug laws in the UK? These are just some of the topics discussed in our latest episode.

**Disclaimer. The views and opinions expressed in this episode are those of the panellists and do not necessarily represent those of the organisations they represent and employed by**

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(62)

What is sober curiosity? With Scott Woolley (Arclett)

What is sober curiosity? With Scott Woolley (Arclett)

What does it mean to question our relationship with alcohol? Founder and Director of Arclett, Scott Woolley, joins Drugs Unwrapped to share his personal journey to becoming alcohol-free and explore th...

29 Sep 37min

Bringing young people's voices to the drug policy table with Ruby Rose Lawlor

Bringing young people's voices to the drug policy table with Ruby Rose Lawlor

We are joined by YouthRise's Executive Director, Ruby Rose Lawlor, to discuss influencing drug policy change at the UN, full spectrum harm reduction and the recent recommendation to decriminalise drug...

14 Sep 52min

Developing digital infrastructure within harm reduction with Mark Tudor

Developing digital infrastructure within harm reduction with Mark Tudor

In this episode, we are joined by Mark Tudor, co-founder of Substancy. Mark has worked in the harm reduction field for over 30 years, but most recently has established Substancy, a social enterprise t...

1 Juli 30min

What is trauma-informed practice?

What is trauma-informed practice?

We are joined by Sarah, CAVDAS Alliance Manager, to shed light on what trauma-informed practice is and why it matters. Sarah has led Barod's journey towards becoming a trauma-informed organisation and...

17 Juni 37min

Image and Performance Enhancing Drugs: What's the appeal?

Image and Performance Enhancing Drugs: What's the appeal?

In this episode, we are joined by Liberty Musungo, Image and Performance Enhancing Drugs (IPEDs) Lead for Dyfed Drug and Alcohol Service (DDAS). Liberty takes us through what IPEDs are and how they wo...

2 Juni 45min

How do we become anti-stigma?

How do we become anti-stigma?

In this Learning at Work Week special, we are joined by Barod's Operations Manager, Sian, to discuss how we can move from being non-stigmatising, to actively challenging and becoming anti-stigma.In th...

19 Maj 23min

Inside the Green Party’s Plan to Legalise Drugs

Inside the Green Party’s Plan to Legalise Drugs

In this episode, we are joined by Dr. Carrie Hamilton and Michael Wakelyn-Green, from the Green Party Drug Policy Working Group, to explore the party's proposed approach to drug policy. With recent fo...

21 Apr 43min

Drugs on the brain with Professor David Nutt

Drugs on the brain with Professor David Nutt

In this episode, we’re joined by leading neuropsychopharmacologist, Professor David Nutt, for a deep dive into the human brain and its relationship with drugs. We discuss whether our brains are built ...

25 Mars 54min

Populärt inom Samhälle & Kultur

podme-dokumentar
gynning-berg
husmodern-med-amanda-schulman
svenska-fall
aftonbladet-krim
p3-dokumentar
en-mork-historia
rss-kansli-med-jessica-sebastian
rss-creepypodden
flashback-forever
killradet
hor-har
kod-katastrof
rss-schyffert-sundin-ar-det-har-nat
mardromsgasten
p1-dokumentar
vad-blir-det-for-mord
aftonbladet-daily
rss-brott-och-straff
rss-hemlispodden